Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Ole B. Suhr, Mitsuharu Ueda et al.|New England Journal of Medicine|2018Cited by 2.9k
Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesisGaurav V. Harlalka, Andrew H. Crosby, Anna Lehman et al.|Brain|2013Cited by 143